Laboratory Corp. of America Holdings (N:LH)

Business Focus: Healthcare Facilities & Services

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for LH within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 26th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 25/20 Feb 21/20 Wilkinson Peter J Direct Ownership Common Stock S - Open market or private sale -297 $189.65
Feb 21/20 Feb 19/20 Belingard Jean-Luc Direct Ownership Non-qualified Stock Options M - Exercise or conversion exempt under rule 16b-3 -3,100  
Feb 21/20 Feb 19/20 Belingard Jean-Luc Direct Ownership Common Stock S - Open market or private sale -26,479 $189.76
Feb 21/20 Feb 19/20 Belingard Jean-Luc Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 3,100 $77.19
Feb 14/20 Feb 13/20 van der Vaart Sandra D Direct Ownership Common Stock S - Open market or private sale -103 $188.49
Feb 14/20 Feb 13/20 van der Vaart Sandra D Direct Ownership Common Stock S - Open market or private sale -105 $188.49
Feb 14/20 Feb 13/20 Schroeder Mark S Direct Ownership Common Stock S - Open market or private sale -103 $188.49
Feb 14/20 Feb 13/20 Schroeder Mark S Direct Ownership Common Stock S - Open market or private sale -85 $188.49
Feb 14/20 Feb 13/20 Williams R Sanders Direct Ownership Common Stock S - Open market or private sale -1,227 $188.49
Feb 14/20 Feb 12/20 Eisenberg Glenn A Direct Ownership Restricted Stock Unit M - Exercise or conversion exempt under rule 16b-3 -940  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for LH within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 26th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 25/20 Feb 21/20 Wilkinson Peter J Direct Ownership Common Stock S - Open market or private sale -297 $189.65
Feb 21/20 Feb 19/20 Belingard Jean-Luc Direct Ownership Non-qualified Stock Options M - Exercise or conversion exempt under rule 16b-3 -3,100  
Feb 21/20 Feb 19/20 Belingard Jean-Luc Direct Ownership Common Stock S - Open market or private sale -26,479 $189.76
Feb 21/20 Feb 19/20 Belingard Jean-Luc Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 3,100 $77.19
Feb 14/20 Feb 12/20 Eisenberg Glenn A Direct Ownership Restricted Stock Unit M - Exercise or conversion exempt under rule 16b-3 -940  
Feb 14/20 Feb 12/20 Eisenberg Glenn A Direct Ownership Restricted Stock Unit M - Exercise or conversion exempt under rule 16b-3 -780  
Feb 14/20 Feb 12/20 Eisenberg Glenn A Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -280 $187.51
Feb 14/20 Feb 12/20 Eisenberg Glenn A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 940  
Feb 14/20 Feb 12/20 Eisenberg Glenn A Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -232 $187.51
Feb 14/20 Feb 12/20 Eisenberg Glenn A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 780  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $LH

Competitors

Competitors with Recent Insider Filings
CVS Health (N:CVS)
Quest Diagnostics (N:DGX)
Select Medical Holdings (N:SEM)